Skip to main content
Back to Journal Club
Preoperative TXA in Dermatologic Surgery - Bleeding Reduction

Hurst EA, Yu SS, Grekin RC, et al.
Dermatologic Surgery (2007)

JC: November 2024

This study evaluated preoperative oral tranexamic acid (TXA) administration for reducing bleeding complications in dermatologic surgery. The analysis demonstrated that preoperative TXA can decrease intraoperative blood loss and reduce the incidence of postoperative hematoma and ecchymosis, with a favorable safety profile in appropriately selected patients.

Take-Home Messages

  • •Preoperative oral TXA reduces intraoperative bleeding and postoperative hematoma rates in dermatologic surgery.
  • •TXA is particularly beneficial for patients on antiplatelet or anticoagulant therapy undergoing surgical procedures.
  • •Patient selection should exclude those with active thromboembolic disease or significant thrombotic risk factors.
PubMed →DOI →

Topic

Hemostasis & Anticoagulation

TXA, anticoagulation management, bleeding complications

Abstract

Although the overall incidence is low, bleeding complications in dermatologic surgery can occur and be the source of significant patient morbidity. In this article, we summarize the key aspects of preoperative assessment of patients at risk for bleeding. A review of current issues and literature regarding safe continuation of anticoagulant and antiplatelet medications in dermatologic surgery patients is also presented. In addition, principles for management of bleeding events, should they occ...

View on PubMedDOI
Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.